Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats

Developmental Brain Research

Volumn 136, Issue 2, 2002, Pages 85-92

  Romero, Eva M ^a   Fernández, Beatriz ^a   Sagredo, Onintza ^a   Gomez, Nuria ^a   Urigüen, Leyre ^a   Guaza, Carmen ^b   De Miguel, Rosario ^a   Antonio Ramos, Jose ^a   Paz Viveros, M ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b INSTITUTO CAJAL   (Spain)

Author keywords

Corticosterone; Functional response to cannabinoids; Holeboard activity; Modulation by morphine; Nociception; Young rat

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CORTICOSTERONE; DOPAMINE; MORPHINE; NALOXONE; RIMONABANT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BRAIN REGION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; CORTICOSTERONE BLOOD LEVEL; DOPAMINERGIC SYSTEM; FEMALE; FOREBRAIN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMBIC SYSTEM; MALE; MOTOR ACTIVITY; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT;

ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; CANNABINOIDS; CORTICOSTERONE; CYCLOHEXANOLS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; GROOMING; MALE; MARIJUANA ABUSE; MORPHINE; MOTOR ACTIVITY; NALOXONE; NARCOTIC ANTAGONISTS; NEOSTRIATUM; NEUROSECRETORY SYSTEMS; NOCICEPTORS; PAIN MEASUREMENT; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SEX CHARACTERISTICS;

ANIMALIA;

EID: 0037199107     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(02)00306-1     Document Type: Article

References (36)

1. The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats
2. 9-Tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain
3. Behavioral effects of cannabinoid agents in animals
4. Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders
5. Naltrindole administration during the preweanling period and manipulation affect adrenocortical reactivity in young rats
6. Effects of neonatal naltrindole treatment on antinociceptive and behavioral responses to μ and κ agonists in rats
7. The endogenous cannabinoid system and brain development
8. Role of endocannabinoids in brain development
9. Developmental aspects of anandamide: Ontogeny of response and prenatal exposure
10. 9-tetrahydrocannabinol in mice
11. Cannabinoids as potential new analgesics
12. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum
13. 9-THC and anandamide
14. Low level lead exposure alters morphine antinociception in neonatal rats
15. The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats
16. 9-tetrahydrocannabinol in rats
17. Pharmacological and biochemical interactions between opioids and cannabinoids
18. 8-tetrahydrocannabinol-dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats
19. Cannabinoid modulation of rat pup ultrasonic vocalizations
20. Aversive effects of the synthetic cannabinoid CP 55,940 in rats
21. Cannabinoid receptors in developing rats: Detection of mRNA and receptor binding
22. 9-tetrahydrocannabinol: Possible involvement of nigrostriatal dopaminergic alterations
23. Involvement of Dinorphin B in the antinociceptive effects of the cannabinoid CP 55,940 in the spinal cord
24. 9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas
25. 1 in the nesotelencephalic dopaminergic neurons physiology
26. Presence of cannabinoid binding sites in the brain from early postnatal ages
27. Atypical location of cannabinoid receptors in white matter areas during rat brain development
28. Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: An in situ hybridization study
29. In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: Behavioral and cellular responses after acute and chronic treatments
30. Activational role of cannabinoids on movement
31. 9-tetrahydrocannabinol
32. Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors
33. 9-Tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: Reduction in morphine withdrawal syndrome without change in rewarding effect
34. Effects of social isolation and crowding upon adrenocortical reactivity and behavior in the rat
35. Synergistic interactions of endogenous opioids and cannabinoid systems
36. Arachidonyl ethanolamide (anandamide) activates the parvocellular part of hypothalamic paraventricular nucleus